Lower or higher blood-pressure targets for high-risk patients?

被引：0
|
作者：
Alberto Zanchetti
机构：
[1] Alberto Zanchetti is at the Istituto Auxologico Italiano (IRCCS) and Centro Interuniversitario di Fisiologia Clinica e Ipertensione,
[2] Università degli Studi di Milano,undefined
[3] Via Ariosto 13,undefined
[4] 20145 Milan,undefined
[5] Italy.,undefined
来源：
Nature Reviews Cardiology | 2016年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Blood-pressure lowering has undisputable benefits, but the optimal values to which blood pressure should be lowered are debated. Interpretation of recent trials is controversial, and post-hoc analyses to investigate the inflection point of the curve relating events to blood pressure are disputed. Meta-analyses of randomized trials and prospective, cohort studies might guide decision-making.
引用
收藏
页码：637 / 638
页数：1
相关论文
共 50 条
12345